Alternative Energy and Clean Technology

MBM single industries-served alternative energy

Rising energy and commodity prices, energy security, climate change and water constraints are forcing a global transformation in the way energy and natural resources are produced, distributed and consumed. Businesses and capital organizations are committed to the production of responsible and sustainable uses of energy and alternative energy sources which have endless opportunities for technological innovation.

MBM’s experienced professionals are notably positioned at the forefront of this groundbreaking opportunity in alternative and clean technology. Our team provides strategic advice in the following areas:

  • Advanced energy generation (such as solar, wind, geothermal, biomass, waste-to-energy, natural gas, cleaner coal and hydrokinetic),

  • Fuel Cells, and other energy storage technologies,

  • Energy efficiency, transmission, distribution, and smart grid,

  • Green buildings,

  • Bio-based chemicals,

  • Electric vehicle, and

  • Bio-fuels.

  • LED based lighting and LED based technology

We also have long standing relationships with leading venture capital firms, private equity firms and energy project investors essential to the development and commercialization of these technologies.

Our clients include several Canadian-based and global companies, from start-ups to large corporations, involved in waste management, sewage disposal, renewable energy generation, wastewater handling and treatment and efficient energy utilization technologies.

Submit to DiggSubmit to FacebookSubmit to Google BookmarksSubmit to StumbleuponSubmit to TwitterSubmit to LinkedIn

cb photo 106 56b90c1f32572

DR. Michael Maskery

Patent Agent

Michael's practice focuses on the patent drafting, prosecution and strategy in a variety of technology fields.MBM read_more_btn


MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More